Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

A recent drug discovery could eventually help the visually impaired and those suffering from multiple sclerosis, traumatic stroke, and Alzheimer’s disease regain some of their vision and mental ...

MZ will work closely with Quantum BioPharma management to develop and implement a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment ...

She states symptoms as including: Pedra Lhermitte's Sign (electric shock sensation), facial pain, MS hug, heat intolerance, body jerks, cognitive fog, itching (pruritus), hypersensitivity to light, ...

Mikael Simons, MD, a neurologist in Germany, won this year’s Barancik Prize for his research on myelin, the National MS Society said.

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently ...

It has been hypothesized that autoreactive T cells activated against MAP antigens might cross-react with human myelin epitopes ... of this manuscript. Multiple sclerosis (MS) is a complex disease ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases in Munich, Germany is the winner of the 2024 Barancik Prize for Innovation ...

Multiple sclerosis (MS) is a chronic neurodegenerative autoimmune disease that affects the central nervous system (CNS). It occurs when the immune system mistakenly attacks the myelin sheath ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis ... s immune system mistakenly attacks the myelin, a protective sheath that covers nerve fibers.

The drug, LL-341070, enhances the brain's ability to repair damaged myelin— the protective sheath around nerve fibers. Damage to myelin is a hallmark of diseases like MS, as well as a natural ...